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The progesterone receptor (PR) is a candidate gene for the development of endometriosis, a complex disease with strong hormo-
nal features, common in women of reproductive age. We typed the 306 base pair Alu insertion (AluIns) polymorphism in intron G
of PR in 101 individuals, estimated linkage disequilibrium (LD) between five single-nucleotide polymorphisms (SNPs) across the
PR locus in 980 Australian triads (endometriosis case and two parents) and used transmission disequilibrium testing (TDT) for
association with endometriosis. The five SNPs showed strong pairwise LD, and the AluIns was highly correlated with proximal
SNPs rs1042839 (2 = 0.877, D = 1.00, P < 0.0001) and rs500760 (2 = 0.438, D = 0.942, P < 0.0001). TDT showed weak evidence
of allelic association between endometriosis and rs500760 (P = 0.027) but not in the expected direction. We identified a common
susceptibility haplotype GGGCA across the five SNPs (P = 0.0167) in the whole sample, but likelihood ratio testing of haplotype
transmission and non-transmission of the AluIns and flanking SNPs showed no significant pattern. Further, analysis of our
results pooled with those from two previous studies suggested that neither the T2 allele of the AluIns nor the T1/T2 genotype was
associated with endometriosis.
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Introduction
Endometriosis is a common and complex gynaecological disorder.
Estimates of its true prevalence vary (Zondervan et al., 2002), but
given a proportion of affected women are asymptomatic, the reported
rate of 7% in our large Australian twin study (Treloar et al., 1999)
suggests a lifetime prevalence of around 10%. Endometriosis is influ-
enced by both environmental and genetic factors (Treloar et al.,
1999). There is strong evidence for familial aggregation in population
based samples (Stefansson et al., 2002), hospital samples (Kennedy
et al., 1995; Simpson and Bischoff, 2002), twin studies (Moen, 1994;
Hadfield et al., 1997; Treloar et al., 1999) and in non-human primates
(Zondervan et al., 2004). Finding genes predisposing to endometriosis
will help to define mechanisms of disease, and efforts are being
directed towards association studies of plausible candidate genes, and
more recently towards positional cloning approaches (Kennedy,
2003).
In endometriosis, ectopic endometrium-like tissue continues to pro-
liferate and invade in response to the monthly cycles of ovarian ster-
oid hormones (Meresman et al., 2002). Endometriosis has
characteristics of invasion and metastasis, although pathologically it
resembles a benign tumour (Koninckx et al., 1999). The complex
nature of the disease means variation in many genes may contribute to
disease prevalence. Possible candidates include genes involved in
endometrial tissue proliferation and invasion including those from
steroid hormone pathways. Estrogen is a potent mitogen in the
endometrium and endometriosis (Gurates and Bulun, 2003), whereas
progesterone counteracts the estrogen-dependent proliferation of
endometrial tissue and promotes differentiation (Gurates and Bulun,
2003). Combined oral contraceptives have been shown to down-
regulate cell proliferation and to enhance apoptosis in eutopic
endometrium from women with endometriosis (Meresman et al.,
2002). Endometriosis appears less responsive to the antiproliferative
and differentiating effects of progesterone (Gurates and Bulun, 2003),
but progesterone receptor (PR) modulators are included in the range
of promising new medical treatments for endometriosis (D’Hooghe,
2003).
Steroid receptor gene polymorphisms and protein changes have
been correlated with endometriosis (Moutsatsou and Sekeris, 2003).
The chromosomal region on 11q22-23 encompassing the PR gene is a
frequent site for loss of heterozygosity in women with endometriosis
(Jiang et al., 1996). Response to progestins may differ in women with
endometriosis and differential PR expression has been reported in
endometriotic tissue compared with eutopic endometrium (Jiang
et al., 2002). Variants in PR include rs1042838 in exon 4, rs1042839
in exon 5 and an Alu insertion (AluIns) polymorphism in intron 7
(Rowe et al., 1995). There is strong but not complete linkage disequi-
librium (LD) between these variants, and the combination of the T
allele at rs1042838, T allele at rs1042839 and the AluIns has been
referred to as PROGINS (Agoulnik et al., 1997; Kieback et al., 1998).
Evidence for the direct involvement of the PR gene in endometriosis
comes from two small case-control studies that reported a significant
association between the T2 AluIns allele of the intron G (PROGINS)
of the PR gene (Wieser et al., 2002; Lattuada et al., 2004). A two-fold
increase in risk of endometriosis in women carrying the T2 allele was
found from analysis of the combined data from both studies (Lattuada
et al., 2004). The same pathophysiology may contribute to progression
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of endometriosis and transformation to endometrioid or clear cell
ovarian neoplasias (Ness, 2003). The PROGINS AluIns element (T2
allele) has been associated with sporadic ovarian carcinoma (Rowe
et al., 1995) and the PROGINS complex has been associated with the
prevalence of ovarian cancer in women carrying BRCA1 and BRCA2
mutations (Runnebaum et al., 2001).
The human PR gene encodes several transcripts with two major
isoforms, PR-A and PR-B, regulated by distinct promoter regions
(Kastner et al., 1990). Transcription from separate promoters and
translational start sites give rise to the major isoforms PR-A and PR-B,
which are identical except for an additional 165 amino acids present
only in the N terminus of PR-B (Conneely et al., 1987, 1989; Kastner
et al., 1990). Although PR-A and PR-B share several structural
domains, they are distinct transcription factors that mediate their own
response genes and physiologic effects with little overlap (Conneely
et al., 2003). A SNP in the promoter of PR (+331G/A; rs10895068)
creates a unique start site which increases transcription of the PR-B
isoform and has been associated with increased risk for developing
endometrial cancer (De Vivo et al., 2002). A second polymorphism in
the promoter region (+44C/T; rs518162), identified also by De Vivo
et al. (2002) was not associated with endometrial cancer. Expression
of the major isoforms may be altered in endometriotic lesions, but
results are inconsistent. In one study a higher ratio of PR-B to PR-A
mRNA was found in ectopic compared with eutopic endometrial tis-
sue (Misao et al., 1999), whereas in another, PR-B mRNA was absent
from endometriotic tissue (Attia et al., 2000).
In summary, variation in the PR may contribute to the incidence of
endometriosis and related ovarian cancers (Del Carmen et al., 2003).
Therefore we tested association between endometriosis and genetic pol-
ymorphism in the PR by analysing selected single-nucleotide polymor-
phisms (SNPs) across the locus in a sample of 980 triads (affected
individual and both parents) from our Australian study of endometriosis
(Treloar et al., 2002). Because typing the AluIns polymorphism is
labour intensive, we typed it in only a subsample and used strong LD
with one of the flanking SNPs to infer presence/absence of the insertion.
Materials and methods
Participants and sample collection
Samples and genotype data were from Australian participants in the Interna-
tional Endogene Study, recruited between 1996 and 2002 (Treloar et al.,
2002). The median age at participation of affected daughters was 31 years,
with a range of 16–54 years. Median age at diagnosis reported by daughters
was 24 years, with a range of 12–50 years. Participants were mostly of Euro-
pean ancestry (Treloar et al., 2002). The Australian study recruited 1055 triads
of affected women plus two parents, of which 980 families provided adequate
DNA. Triads were independent of 931 recruited affected sister-pair families
used in our parallel linkage study. All women had been diagnosed by surgical
means, with visualisation a minimum requirement for inclusion. Revised
American Fertility Society (rAFS) criteria (American Fertility Society, 1985)
were used for staging of disease severity (Treloar et al., 2002). The project was
approved by the Human Research Ethics Committee of the Queensland Insti-
tute of Medical Research and all DNA samples were collected with written,
informed consent.
Triads included daughters with all rAFS stages of endometriosis. We used
two broad categories: stage A (minimal to mild, N = 673, 69%) and stage B
(moderate to severe, N = 307, 31%) for stratified analyses, given that stage was
in some cases assigned retrospectively (Treloar et al., 2002). Subfertility was
measured by reported problems conceiving. In this sample, 388 daughters who
had tested their fertility (40%) reported problems conceiving and 215 (22%)
reported no problems; 377 cases (38%) had never tried to conceive. In those
who had tested their fertility there was a strong positive association (χ12 = 24.45,
P < 0.0001) between more severe stage and subfertility in this sample, with
minimal–mild endometriosis having a relatively protective effect (OR = 0.38,
95% CI = 0.25–0.56).
DNA was extracted from peripheral blood lymphocytes by the salt precipita-
tion method (Miller et al., 1988) and was then stored at 4°C at Queensland
Institute of Medical Research (QIMR, Brisbane, Australia). Two participants
provided a buccal swab sample and DNA was extracted from buccal swabs
using Microcon Centrifugal Filter Devices (Amicons) and stored at 4°C. Aliq-
uots of sample genomic DNA were adjusted to final concentrations of 3 ng/ul
and 10 ng/ul for Sequenom™ MassARRAY and AluIns PCR, respectively.
SNP selection
We selected four polymorphisms in the PR gene on the basis of published
reports: the 306 base pair AluIns in intron G, part of the PROGINS complex,
which had been reported to be associated with endometriosis (Wieser et al.,
2002), a functional polymorphism +331G/A (rs10895068) in the promoter
region associated with risk of endometrial cancer and two further SNPs,
rs518162 and rs1042838 (Val660Leu), identified by De Vivo et al. (2002).
Five additional SNPs–rs208112, rs3740754 (Ser344Thr), rs1042839
(His770His), rs2020880 (Leu865Ser) and rs500760 (Gln886Gln), the latter
two flanking the AluIns–were selected from the NCBI database (NCBI Gen-
Bank Database, entry ×51730, human mRNA and promoter DNA for the PR).
Three SNPs, rs2008112; rs3740754 and rs2020880 were monomorphic in our
sample and were excluded from data analyses. Figure 1 shows the positions of
the SNPs genotyped in the PR gene.
Genotyping
Forward and reverse PCR primers and a primer extension probe were designed
using SpectroDESIGNER software (Sequenom™, San Diego, CA, USA) and
assembled into a multiplex set. SNPs were typed using the Sequenom™ matrix-
assisted laser desorption/ionization-time of flight (MALDI-TOF) MassARRAY
protocol. The PCR volume of 5 μl contained 15 ng DNA, 10× PCR buffer, 25
mM MgCl2, 25 mM dNTP, forward and reverse primers to a final concentration
of 50 nM for all SNPs (excluding rs10895068 which was 75 nM) and 5 U/μl of
Taq polymerase. PCR cycling conditions were an initial denaturation step of 15
min at 95°C, followed by 45 cycles of 20 s at 95°C, 30 s at 56°C, 1 min at 72°C
and a final extension step of 3 min at 72°C. To neutralize and remove residual
unincorporated dNTPs from the PCR, shrimp alkaline phosphatase (1 U/μl) was
added and the reaction incubated at 37°C for 20 min and then 85°C for 5 min.
The MassEXTEND PCR mix contained allele-specific extension primers at
300nM each, h-ME (ACT or ACG) extension mix and 32 U/μl of ThermoSe-
quenase. PCR cycling conditions were a denaturation step of 2 min at 94°C,
followed by 55 cycles of 5 s at 94°C, 5 s at 52°C and 5 s at 72°C. Purification
of h-ME reaction products was performed by the addition of resin. Primer
products were spotted onto 384-well chips, precoated with a 3-hydroxypico-
linic acid matrix, to help bind and stabilize DNA during ionisation by the
MassARRAY. Loading of the products was performed using a nanolitre pipet-
ting system (SpectroCHIP, SpectroJet; Sequenom) and reaction products analysed
through MALDI-TOF MassARRAY (Sequenom).
We used a modified protocol to examine the presence/absence of the AluIns
polymorphism in a subsample (Spurdle et al., 2002). A subset of DNA samples
Figure 1. Progesterone receptor (PR) gene showing relative positions of
single-nucleotide polymorphisms (SNPs) investigated in the study; SNPs that
were polymorphic in our sample are indicated by solid arrow lines and bold
black font; SNPS that were non-polymorphic in our sample are in grey font
and SNPs which appear in HapMap (The International HapMap Consortium,
2003) are in italics.
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(n = 101) was typed successfully by PCR using forward and reverse primers 5′-
ATACGGTATCCATGACATGAG-3′ and 5′-AAGTATTTTCTTGCTAAAT-
GTCTG-3′, respectively. The reaction volume of 10 ul contained 15 ng of
DNA, primer concentrations of 10 pmol each, dNTPs (200 nM), 1× Perkin-
Elmer Taq polymerase buffer, 1 unit of Taq polymerase and 1.5 mM MgCl2.
Amplification conditions were an initial denaturation step of 10 min at 94°C,
35 cycles of 94°C for 20 s, 51°C for 20 s, 72°C for 60 s and a final extension
step of 72°C for 10 min. PCR products of 65 bp for wild type and 385 bp with
AluIns were resolved on a 2.5% agarose gel (Agarose 1000 UltraPure, Invitrogen,
Carlsbad, CA, USA).
Statistical analysis
To avoid spurious associations arising from population admixture we used a
family-based design to study parental alleles/haplotypes transmitted and not
transmitted to affected offspring. Our strategy for data analysis was based on
(i) typing selected SNPs in the triad set as outlined, (ii) typing the AluIns in a
subset of individuals, (iii) estimating LD between the AluIns and flanking
SNPs, and between all the SNPs typed and (iv) using the transmission disequi-
librium test (TDT) for detecting association between endometriosis and indi-
vidual SNP and haplotypes. Because inference about association between the
AluIns and endometriosis depends on the extent of LD with its proximal SNPs,
it was important to estimate LD before proceeding.
Data handling was performed using SAS (SAS Institute Inc., 2001) and
Mendelian error checking using SIB-PAIR software (Duffy, 2001). For esti-
mating LD between pairs of variants in the PR gene, in addition to Lewontin’s
D′ linkage disequilibrium statistic, we also estimated Δ2, effectively providing
an estimate of inter-SNP correlation (r = √Δ2). LD between the SNPs across
the gene was estimated using SNPSpD (Nyholt, 2004). LD calculations invol-
ving the AluIns were based on data from up to 101 individuals, and for other
SNPs using data based on individuals in the 980 triads, numbers ranged
between 2889 and 2913.
The single-locus TDT (Spielman et al., 1993), a robust test for allelic associ-
ation in the presence of population stratification, which uses information from
heterozygous parents, was performed on SNP data from 980 cases and both
parents (2940 individuals) using SIB-PAIR software (Duffy, 2001). This TDT
statistic is the Pearson goodness-of-fit based test of symmetry in the square
table of transmitted versus non-transmitted alleles to each affected child
(Haberman, 1979). The genotypic TDT P-value is estimated through gene-
dropping based on the genotypes of both typed parents of the proband. The test
statistic compares the observed number of each genotype transmitted with the
number expected based on the parental genotypes. Multi-locus TDT, using a
sliding window approach across the 5 SNP genotypes, was performed using
GENEHUNTER 2.0 (Kruglyak et al., 1996) to compare the frequencies of
transmitted and untransmitted SNP haplotypes, excluding the AluIns. These
analyses were also performed for phenotypic strata of endometriosis families,
to assess whether any effects were restricted to certain phenotypes. We strati-
fied triad families according to three important phenotypes of cases: age at
diagnosis, subfertility and disease stage.
We first estimated haplotype frequencies between AluIns and proximal
SNPS rs1042839 and rs500760 in 87 affected probands where complete
data were available, using ARLEQUIN version 2.000 (Schneider et al.,
2000). Because we did not type the full PROGINS complex and typed the
AluIns component in a relatively small subsample, we conducted a final
check of haplotype transmission. We used TDTPHASE (Dudbridge, 2004)
to imput the missing genotypes, enabling estimation of haplotypes for the
AluIns and its two flanking SNPs for a much larger sample, and to conduct
a full likelihood ratio test in a log-linear model using the expectation
maximization (EM) algorithm to obtain maximum-likelihood estimates for
haplotype transmission disequilibrium.
Finally, given the strong LD between the AluIns and rs1042839, we used the
latter alleles and genotypes to draw comparisons and analyse pooled results
from our own and the Austrian (Wieser et al., 2002) and Italian (Lattuada
et al., 2004) studies. Because of the different designs, we used transmitted and
untransmitted alleles of rs1042839, which was in strong LD with the AluIns in
the Australian data, to combine with case and control data, respectively, from
other studies. Given the significant heterogeneity between the results of the
three studies, a pooled allelic odds ratio was calculated, under a random effects
model, from genotype counts using the methods of DerSimonian and Laird
(1986) and Whitehead and Whitehead (1991).
Results
All SNPs were in Hardy–Weinberg equilibrium (probabilities 0.37–0.84,
restricted to founders). Minor allele frequencies for the five SNPs in
founders ranged from 0.061 to 0.241 (Table I), and for the minor (T2)
allele of the AluIns was 0.124 (N = 101).
There was evidence for significant allelic association with endome-
triosis for SNP rs500760 in exon 8 (P = 0.0270), with the ratio of
transmission to non-transmission for the A allele of 386:326 (Table II).
Genotypic transmission disequilibrium was not significant (empirical
P = 0.075). Results were consistent when triads involving identically
heterozygous parents were removed from analysis (P = 0.026). There
was no evidence for association with SNPs in the promoter region of
PR.
There was strong LD across the PR locus (Table III). Five com-
mon haplotypes accounted for more than 99% of chromosomes in
the sample (Table IV). There was significant over-transmission of
the GGGCA haplotype (378:315, P = 0.017), but no significant
Table I. Single-nucleotide polymorphisms (SNPs) at the progesterone 
receptor (PR) locus genotyped in 980 triad families (N = 2940) with 
endometriosis




rs518162 –700 5′UTR G>A 0.068
rs2008112 –569 5′UTR G>A Monomorphic
rs10895068 –413 5′UTR G>A 0.061
rs3740754 168 Exon 1 G>C Monomorphic
rs1042838 66389 Exon 4 G>T 0.155
rs1042839 77599 Exon 5 C>T 0.154
rs2020880 87073 Exon 7 C>T Monomorphic
rs500760 89810 Exon 8 A>G 0.241
Table II. Association (TDT) between endometriosis and single-nucleotide 
polymorphisms (SNPs) at the progesterone receptor (PR) locus





rs518162 225 1.4 G 0.270
rs10895068 210 0.0 G 0.894
rs1042838 438 0.7 G 0.420
rs1042839 435 1.0 C 0.345
rs500760 581 5.1 A 0.027
Table III. Linkage disequilibrium D′ (values denoted with *) and Δ2 (values 
denoted with †) measures of association between pairs of variants in the 
progesterone receptor (PR) gene
Δ is the correlation between two biallelic variants. Significant χ2 values 
(P < 0.0001) are in bold. All single-nucleotide polymorphism (SNPs) typed 
on 2867–2881 samples. AluIns typed on 101 individuals including 87 affected 
probands.
Variant 1 Variant 2
rs518162 rs10895068 rs1042838 Rs1042839 AluIns rs500760
rs518162 – 0.998* 0.995* 0.995* 0.757* 0.999*
rs10895068 0.005† – 0.996* 0.995* 1.000* 0.999*
rs1042838 0.013† 0.012† – 0.996* 0.951* 0.984*
rs1042839 0.013† 0.012† 0.984† – 1.000* 0.987*
AluIns 0.005† 0.007† 0.826† 0.877† – 0.942*
rs500760 0.022† 0.020† 0.570† 0.568† 0.438† –
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under-transmission or ‘protective’ haplotype. This result stood with
the more stringent test after eliminating triads with double-heterozygous
parents, although the significance level for the susceptibility haplo-
type decreased to P = 0.041 (Table IV).
We stratified triad families according to phenotype of cases: age at
diagnosis, subfertility and disease stage. There were no effects of age
at diagnosis. The association with rs500760 was very strong in the
subgroup reporting subfertility (problems conceiving), with overtrans-
mission of the A allele and consequent undertransmission of G allele
(P = 0.007, Table V). No association was shown in either those who
reported no problems conceiving or in those who had never tried con-
ceiving. Interestingly, the evidence for allelic association between
endometriosis and rs500760 was also increased in triads with stage A
(minimal to mild) disease (P = 0.006), despite the negative phenotypic
association between subfertility and disease stage. In triads with stage
B (moderate to severe) disease, there was no association with
rs500760 and no significant association with any other SNP. Over the
five SNPs, there was both a significant susceptibility and a protective
haplotype in stage A probands (Table V). When triads with double
heterozygote parents were removed from analysis, the evidence for
significance of the GGGCA susceptibility haplotype decreased to P =
0.049, and that of the protective GGTTG haplotype increased to P =
0.0280. In the subset of families with both subfertility and minimal–
mild disease overtransmission of the GGGCA haplotype failed to
reach significance. The GGGCG haplotype appeared protective,
although numbers were small.
Inference about association between the AluIns and endometriosis
depends on the extent of LD with its proximal SNPs. We estimated
Δ2, effectively providing an estimate of inter-SNP correlation r = √Δ2.
There was very strong LD between rs1042839 and the AluIns (Δ2 =
0.877, D′ = 1.000, P = 0.000). LD between the AluIns and rs500760
was also strong but not complete (Δ2 = 0.438, D′ = 0.942, P = 0.000),
and similarly between the two flanking SNPs themselves (Δ2 = 0.568,
D′ = 0.987, P = 0.000). Analysis of LD between the AluIns and the
two flanking markers in 99 individuals typed for all three markers
showed that the C T1 A haplotype accounted for 74% of PR chromo-
somes in these families, and the T T2 G haplotype accounted for only
13% of the 87 affected probands typed for the AluIns (Table VI). Fur-
ther, the low frequency of the T T1 G haplotype suggests a misclassifi-
cation rate of no more than 2% if the T G haplotype for rs1042839 and
rs500760 were used to infer the AluIns genotype.
Because we did not type the full PROGINS complex and typed the
AluIns component in a subsample, we assessed haplotype transmis-
sion of the AluIns and its flanking SNPs, imputing missing genotypes
using TDTPHASE (Dudbridge, 2004). The non-significant likelihood
ratio statistic of 6.259, df = 5 (P = 0.2818), excluding rare haplotypes,
suggested no haplotype transmission disequilibrium and provided no
reason to modify our conclusion that our data suggested no convinc-
ing evidence for association between the AluIns and endometriosis.
Given the strong LD between the AluIns and rs1042839, we used
the latter alleles and genotypes to draw comparisons and analyse
pooled results from our own and the Austrian (Wieser et al., 2002)
and Italian (Lattuada et al., 2004) studies. Because of the different
designs, we used transmitted and untransmitted alleles of rs1042839,
which was in strong LD with the AluIns in the Australian data, to
combine with case and control data, respectively, from other studies.
Combined analysis suggests that a significant risk effect of the
T2 allele or of the T1/T2 genotype for endometriosis is unlikely
(Table VII).
Discussion
The AluIns polymorphism in intron G of the PR gene was reported to
be associated with susceptibility to endometriosis (Wieser et al., 2002;
Lattuada et al., 2004). There is strong LD between two SNP variants
(rs1042838 in exon 4, rs1042839 in exon 5) and the AluIns polymor-
phism (Agoulnik et al., 1997; Kieback et al., 1998). We therefore
investigated five SNPs in the PR gene for association with endometri-
osis in a large set of Australian families with clinically confirmed
endometriosis. We typed the two SNPs reported in LD with the
AluIns polymorphism (rs1042838 and rs1042839), one SNP in exon 8
Table IV. Frequency of transmitted and untransmitted progesterone receptor 
(PR) haplotypes (rs518162, rs10895068, rs1042838, rs1042839, rs500760) 
with frequency greater than one
Haplotype Transmitted Untransmitted χ2 P
AGGCA 99 112 0.80 0.822
GAGCA 101 90 0.63 0.426
GGTCG 3 1 1.00 0.317
GGTTA 4 2 0.67 0.414
GGTTG 173 203 2.39 0.122
GGGCA 378 315 5.73 0.017
GGGCG 101 130 3.64 0.056
GGGTA 0 2 2.00 0.157
Table V. Significant transmission of progesterone receptor (PR) haplotypes (rs518162, rs10895068, rs1042838, rs1042839, rs500760) for phenotypic strata of 
endometriosis families
*Daughters diagnosed with endometriosis reporting problems conceiving.
Phenotypic stratum SNP Allele/haplotype Transmitted Untransmitted N χ2 P
Subfertility
Subfertility+* rs500760 A 168 121 231 7.60 0.007
No subfertility rs500760 A 81 79 135 0.00 0.937
Never tried conceiving rs500760 A 137 126 215 0.05 0.538
Disease stage
Stage A rs500760 A 277 217 404 7.30 0.008
Stage B rs500760 A 109 109 177 0.00 1.000
Stage A rs518162– GGGCA 271 218 5.74 0.017
rs500760 GGTTG 116 150 4.35 0.037
Subfertility and 
stage A
rs500760 A 108 71 7.65 0.006
rs518162– GGGCA 104 80 3.13 0.077
rs500760 GGGCG 22 40 5.23 0.022
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flanking the AluIns polymorphism (rs500760) and two SNPs in the
promoter region (rs518162 and rs10895068) including +331G/A
(rs10895068) reported to be associated with endometrial cancer (De
Vivo et al., 2002). We found no association between rs1042838 or
rs1042839 and endometriosis in our families, and unconvincing evid-
ence of association between endometriosis and the exon 8 SNP
rs500760. The confidence bounds of the association were broad con-
sidering multiple testing, so we consider the association to be mar-
ginal. If multiple comparison adjustment is made using a false
discovery rate (Benjamini and Hochnerg, 1995) of 0.05, neither the
result in Table II (P = 0.027) nor in Table IV (P = 0.017) is signific-
ant. Further, the rs500760 SNP is located in the third codon position
(Gln886Gln) and may not have functional significance.
Our results cannot be interpreted as supporting association
between variation in PR and susceptibility to endometriosis and do
not replicate previous findings. The AluIns has been reported in
complete LD with the two exonic SNPs, rs1042838 and 3764C/T
(Spurdle et al., 2001; De Vivo et al., 2002). We genotyped the
AluIns allele in a subset of samples. Our data showed very strong,
but not complete LD. The frequency of the AluIns mutant T2 allele
in our 87 typed endometriosis probands was 0.128, approximately
mid-way between its frequency in cases (0.17) and controls (0.08) in
the Austrian study (Wieser et al., 2002) and the Italian study (0.17
for cases and 0.11 for controls) (Lattuada et al., 2004). Our T2 fre-
quency was also lower than the frequency of 0.16% reported for an
Australian control sample (Spurdle et al., 2002). The homozygote
AluIns was rare in our sample (n = 2, 1.9%), slightly less common
than the 3% and 2.52% observed in ovarian cancer cases and con-
trols, respectively (Spurdle et al., 2001), although our standard error
would be very high. Our heterozygote T1/T2 genotype was 23%,
compared to the 22% and 21% reported for ovarian cases and con-
trols (Spurdle et al., 2001).
Unlike Lattuada et al.’s study (2004), there was no trend for
increased prevalence of the mutant T2 allele in cases of more severe
disease stage. In fact, the T1/T1 genotype was much more prevalent in
cases of stage B disease (87%) compared with stage A disease (66%),
and the heterozygous T1/T2 genotype was more prevalent in stage A
than stage B cases (32% compared with 11%) (P = 0.055). Given that
we found a stronger association with rs500760 and endometriosis in
women with minimal to mild disease, and given the very strong LD
between the PR AluIns polymorphism and proximal SNPs, no associ-
ation could be inferred for endometriosis with the T2 allele in our
Table VII. Summary and pooled analysis of Alu insertion (AluIns) and endometriosis in three studies
CI, confidence interval; OR, odds ratio.
*Published results.
†rs1042839,a flanking SNP in strong linkage disequilibrium (LD) with the AluIns.
‡Frequency in parents minus frequency in affected daughters.
§We pooled major alleles (C) of rs1042839 from the Australian data with the T1 major allele of the AluIns and T minor allele of rs1042839 with the T2 AluIns 
allele from the other studies. Because of heterogeneity among the three studies, pooled allelic odds ratios were calculated under a random effects model from 
genotype counts (DerSimonian and Laird, 1986; Whitehead and Whitehead, 1991).
¶We pooled T/T, T/C and C/C from rs1042839 with T2/T2, T2/T1 and T1/T1 genotypes from the AluIns, respectively, in other studies.
Study Allele Cases Controls OR 95% CI
Austrian (Wieser et al., 2002) T2 33 17
T1 157 197 2.41* 1.31–4.53*
Italian (Lattuada et al., 2004) T2 45 28
T1 217 226 1.7* 1.0–2.8*
Transmitted† Untransmitted†
Australian T 293 305
C 1641 1637 0.96 0.81–1.14
Pooled analysis of alleles§ T2/T 371 350
T1/C 2015 2060 1.20 0.91–1.48
Genotype Cases Controls Trend χ2 P
Austrian (Wieser et al., 2002) T2/T2 3 1
T2/T1 27 15
T1/T1 65 91 7.88 0.005
Italian (Lattuada et al., 2004) T2/T2 3 1
T2/T1 39 26
T1/T1 89 100 4.16 0.041*
Transmitted Untransmitted‡
Australian† T/T 25 22
T/C 243 261
C/C 699 688 0.23 0.633
Transmitted Untransmitted† Pooled OR 95% CI
Pooled analysis of genotypes¶ T2/T2 31 24
T2/T1 309 302
T1/T1 853 879 1.16 0.92–1.47
Table VI. Haplotype frequencies estimation (Schneider et al., 2000) between 
Alu insertion (AluIns) and proximal single-nucleotide polymorphisms (SNPs), 
rs1042839 and rs500760, in 87 affected probands
Number Haplotype Frequency SD
rs1042839 AluIns rs100760
1 C T1 A 0.744 0.034
2 T T2 G 0.131 0.026
3 C T1 G 0.107 0.024
4 T T1 G 0.018 0.010
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data; it was not evident particularly in cases of moderate–severe dis-
ease. Therefore we did not replicate findings from the earlier two case
control studies. Results of pooling of our data, using a flanking SNP
(rs1042839) in strong LD with the AluIns, with the published data
from the Austrian (Wieser et al., 2002) and Italian (Lattuada et al.,
2004) studies suggested that association with endometriosis is
unlikely.
There was no evidence for association between endometriosis and
SNPs in the promoter region of the PR gene, which included a func-
tional polymorphism associated with increased endometrial cancer
risk (De Vivo et al., 2002). We found very strong LD across the PR
locus. Serum prolactin levels have been implicated as a cause for
infertility in patients with minimal to mild endometriosis (Gregoriou
et al., 1999; Martinez et al., 2002). The promoter SNP rs10895068
was associated with prolactin levels in a population sample (Westberg
et al., 2004); although this SNP did not show individual association
with endometriosis in our families, or in the subset with minimal–mild
endometriosis and subfertility, it may warrant further investigation.
Like De Vivo et al. (2002), we estimated eight haplotypes with a
frequency greater than 1%, and five common haplotypes. We typed
SNPs in the PR promoter (De Vivo et al., 2002) and SNPs in LD with
the insertion/deletion polymorphism (Wieser et al., 2002) implicated
in endometriosis. Recent data from large scale genotyping across the
human genome typed 44 SNPs across the PR locus (http://www.hap-
map.org). The data show strong LD in general agreement with results
of our study, but greater numbers of SNPs that identify all common
alleles would need to be typed to completely exclude association
between common variants in PR and endometriosis. An in-depth
sequence approach to the PR gene would be necessary to detect allelic
variants that were large in number but individually rare. Nevertheless,
caution is again required as transcriptional differences as unmasked
by microarray studies may well be the result of epigenetic factors,
which are being shown to be increasingly important in influencing
gene expression over the lifespan (Fraga et al., 2005).
The fact that our results did not support the association between
(more severe) endometriosis and the AluIns T2 allele reported in earl-
ier studies may be a function of the poor predictive value of early
studies reporting ‘positive’ findings (Trikalinos et al., 2004); indeed
studies are seldom replicated when the initial sample size is low
(Ioannidis et al., 2001). A more directed approach to targeting poten-
tial candidate genes for future association studies may come from dif-
ferent approaches. Using microarray analysis, Arimoto et al. (2003)
analysed the expression patterns of 23 040 genes of endometrial tissue
in various phases throughout the menstrual cycle. Borthwick et al.
(2003) examined transcript abundance and changes in transcript level
for 60 000 gene targets between normal endometrium in the prolifera-
tive and secretory phases of the menstrual cycle. These studies have
shown altered levels of expression of genes not previously thought to
cycle during the different endometrial phases.
In a recent genome-wide scan of microsatellite markers, we found
linkage between various chromosomal regions and endometriosis
(Treloar et al., 2000; Wicks et al., 2002). Obviously, these regions
warrant further investigation. The genome-wide scan data showed no
evidence for a locus for endometriosis on chromosome 11q (Treloar
et al., 2005). Our findings fail to provide support for association
between variants in PR and endometriosis and demonstrate the com-
plexity of genotype–phenotype associations in this disease.
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